Fly News Breaks for June 27, 2019
Jun 27, 2019 | 07:06 EDT
Canaccord analyst Jason Mills raised his price target on Boston Scientific to $46 from $43 following its analyst day. He said the company laid out an achievable if not conservative long-range plan, with management projecting a +6-9% organic top-line growth. Mills reiterated his Buy rating on Boston Scientific shares.
News For BSX From the Last 2 Days
There are no results for your query BSX